Quark is a US company with its R&D in Israel.  The US Patent and Trademark Office has granted Quark a key patent for its ocular neuro-protectant QPI-1007, covering the treatment of patients suffering from non-arteritic anterior ischemic optic neuropathy (NAION).

http://quarkpharma.com/?p=12340